Private Equity
Saluda Medical Pty, an Australian medical device company, has secured $75 million in financing. The investors were Boston Scientific Corporation and Redmile Group LLC.
1 min read · 01 July 2019
Montage Ventures has raised over $18 million for its second fund, according to an SEC filing. The target is $37.5 million. Based in Menlo Park, California, Montage Ventures invests in financial services, ecommerce, marketplaces and healthcare startups.
1 min read · 01 July 2019
Tara AI, a product management platform, has raised $10 million in Series A funding. Aspect Ventures led the round with participation from Slack Fund, Y Combinator and Moment Ventures.
4 min read · 01 July 2019
San Jose California-based TrapX Security, a cybersecurity firm, has raised $18 million in financing. Ibex Investors led the round with participation from other investors that included BRM, Opus Capital, Intel Capital, Liberty Technology Venture Capital and Strategic Cyber Ventures.
1 min read · 01 July 2019
TDK Ventures has launched a $50 million fund that will invest in early-stage startups in material science, energy/power and related areas. TDK Ventures was formed by Tokyo-based TDK Corporation, an electronics company.
3 min read · 01 July 2019
Century Therapeutics, a biotech firm, has raised $250 million in financing. The investors were Bayer, Versant and Fujifilm Cellular Dynamics Inc.
1 min read · 01 July 2019
Silicon Valley-based venture firm CloudScale Capital Partners LLC has named Matt Bross as a partner. Bross is a former CTO of British Telecom, Williams Communications and Huawei.
3 min read · 01 July 2019
RealWear Inc, a knowledge transfer and training platforms for the connected worker, has raised $80 million in Series B financing. The investors included Teradyne Inc, Bose Ventures, Qualcomm Ventures LLC, Kopin Corporation and JPMorgan.
1 min read · 01 July 2019
Boldstart Ventures has raised over $88 million for its fourth fund, according to an SEC filing. The target is $100 million. New York City-based Boldstart invests in enterprise software.
1 min read · 28 June 2019
Karuna Therapeutics, a biopharmaceutical company primarily focused on developing novel therapies to address disabling neuropsychiatric conditions, has raised $89.2 million for its IPO after pricing its over 5.5 million shares at $16 per share. The stock began trading June 28, 2019 on the NASDAQ under the ticker symbol "KRTX." Goldman Sachs and Citigroup are the lead underwriters. Karuna's pre-IPO backers included ARCH Venture Partners, Fidelity Management & Research Co, Eventide Asset Management, Pivotal bioVenture Partners, Partner Fund Management, Wellcome Trust, Sands Capital and Alexandria Venture Investments.
3 min read · 28 June 2019
